Dr. William Scott Burgin, MD

Dr. Burgin practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Burgin's NPI, 1508891524, was assigned on July 11, 2006. Dr. Burgin graduated from University of North Carolina School of Medicine in 1995. Dr. Burgin holds Florida license ME109671.

Dr. Burgin's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Burgin's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. The medical group on file is USF Therapy Services. Dmand AI also links Dr. Burgin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Burgin practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Burgin's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Burgin is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Burgin's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute mini-stroke (TIA), cerebrovascular disease, epilepsy, migraine and chronic headache and sleep apnea among the conditions Dr. Burgin treats.

CMS data shows 90 Medicare services from Dr. Burgin across 3 procedure codes in 2024, for 105 Medicare patients. Medicare paid $10,882 for them.

CMS counts 105 Medicare patients who saw Dr. Burgin in 2024. The largest group is 75 to 84, with 42 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Burgin's median patient age at 71, with 36% women.

In 2020, Dr. Burgin wrote 12 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $539 in total drug cost. In 2019, CMS named 15 claims across 1 drug.

Dr. Burgin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Burgin as offering telehealth.

Dmand AI links 54 papers to Dr. Burgin, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Stroke, Brain Ischemia and Tissue Plasminogen Activator. Dr. Burgin has published most often in Stroke. Dr. Burgin's most frequent co-authors are David Z. Rose, MD, James C. Grotta, MD and Maxim Vladimirovich Mokin, MD.

Dmand AI links Dr. Burgin to 6 clinical trials, 2 of them phase 3 studies. 2 are still active or recruiting. Conditions studied include Ischemic Stroke, Stroke and Aphasia. University of South Florida sponsors the most, 2.

CMS Open Payments shows 34 general payments to Dr. Burgin from 11 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 73% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $6,455. It also lists 3 research payments totaling $5,940 in 2017.

Dmand AI lists 6 awards for Dr. Burgin, most recently Neurology Faculty Teaching Award in 2006.

Dr. Burgin graduated from University of North Carolina School of Medicine in 1995.

Dr. Burgin is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.